Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles

Josh Sullivan

In January, Atara Biotherapeutics inked a deal with Fujifilm Diosynth to exchange its California manufacturing site for $100 million upfront, and a long-term licensing deal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles

Josh Sullivan

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Fu­ji­film com­pletes ac­qui­si­tion of Atara's cell ther­a­py man­u­fac­tur­ing site near Los An­ge­les

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles